{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:49:06Z","timestamp":1779907746530,"version":"3.53.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T00:00:00Z","timestamp":1297296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1038\/hr.2011.11","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T10:16:01Z","timestamp":1297332961000},"page":"686-692","source":"Crossref","is-referenced-by-count":31,"title":["Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase"],"prefix":"10.1038","volume":"34","author":[{"given":"Shunichi","family":"Takiguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ayaori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Uto-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonpei","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Ohsuzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Ikewaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,10]]},"reference":[{"key":"BFhr201111_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJM199007053230105","volume":"323","author":"JA Panza","year":"1990","unstructured":"Panza JA, Quyyumi AA, Brush Jr JE, Epstein SE . Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22\u201327.","journal-title":"N Engl J Med"},{"key":"BFhr201111_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/01.HYP.32.1.25","volume":"32","author":"L Ghiadoni","year":"1998","unstructured":"Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M, Di Venanzio L, Salvetti A . Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 1998; 32: 25\u201332.","journal-title":"Hypertension"},{"key":"BFhr201111_CR3","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1097\/00004872-200209000-00001","volume":"20","author":"S Taddei","year":"2002","unstructured":"Taddei S, Salvetti A . Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 2002; 20: 1671\u20131674.","journal-title":"J Hypertens"},{"key":"BFhr201111_CR4","doi-asserted-by":"publisher","first-page":"115S","DOI":"10.1016\/S0895-7061(02)03006-6","volume":"15","author":"EL Schiffrin","year":"2002","unstructured":"Schiffrin EL . Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens 2002; 15: 115S\u2013122S.","journal-title":"Am J Hypertens"},{"key":"BFhr201111_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF03256593","volume":"9","author":"MM Al Khalaf","year":"2009","unstructured":"Al Khalaf MM, Thalib L, Doi SA . Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis. Am J Cardiovasc Drugs 2009; 9: 29\u201343.","journal-title":"Am J Cardiovasc Drugs"},{"key":"BFhr201111_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/01.CIR.103.6.799","volume":"103","author":"B Hornig","year":"2001","unstructured":"Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, Tatge H, Drexler H . Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 2001; 103: 799\u2013805.","journal-title":"Circulation"},{"key":"BFhr201111_CR7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1161\/01.HYP.0000070956.57418.22","volume":"41","author":"L Ghiadoni","year":"2003","unstructured":"Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, Salvetti A . Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41: 1281\u20131286.","journal-title":"Hypertension"},{"key":"BFhr201111_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1291\/hypres.28.889","volume":"28","author":"T Oshima","year":"2005","unstructured":"Oshima T, Ozono R, Yano Y, Higashi Y, Teragawa H, Miho N, Ishida T, Ishida M, Yoshizumi M, Kambe M . Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension. Hypertens Res 2005; 28: 889\u2013894.","journal-title":"Hypertens Res"},{"key":"BFhr201111_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/CRD.0b013e3181b18e03","volume":"17","author":"ES Androulakis","year":"2009","unstructured":"Androulakis ES, Tousoulis D, Papageorgiou N, Tsioufis C, Kallikazaros I, Stefanadis C . Essential hypertension: is there a role for inflammatory mechanisms? Cardiol Rev 2009; 17: 216\u2013221.","journal-title":"Cardiol Rev"},{"key":"BFhr201111_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ncpcardio1211","volume":"5","author":"U Forstermann","year":"2008","unstructured":"Forstermann U . Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 2008; 5: 338\u2013349.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"BFhr201111_CR11","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1172\/JCI116149","volume":"90","author":"A Calver","year":"1992","unstructured":"Calver A, Collier J, Vallance P . Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90: 2548\u20132554.","journal-title":"J Clin Invest"},{"key":"BFhr201111_CR12","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/0735-1097(94)90164-3","volume":"24","author":"DM Gilligan","year":"1994","unstructured":"Gilligan DM, Sack MN, Guetta V, Casino PR, Quyyumi AA, Rader DJ, Panza JA, Cannon III RO . Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 1994; 24: 1611\u20131617.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201111_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/01.CIR.0000138745.21879.27","volume":"110","author":"F Perticone","year":"2004","unstructured":"Perticone F, Maio R, Tripepi G, Zoccali C . Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004; 110: 821\u2013825.","journal-title":"Circulation"},{"key":"BFhr201111_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1291\/hypres.26.771","volume":"26","author":"Y Imai","year":"2003","unstructured":"Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, Miyakawa M, Fukiyama K . Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26: 771\u2013782.","journal-title":"Hypertens Res"},{"key":"BFhr201111_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00126097-200112000-00007","volume":"6","author":"O Shirasaki","year":"2001","unstructured":"Shirasaki O, Terada H, Niwano K, Nakanishi T, Kanai M, Miyawaki Y, Souma T, Tanaka T, Kusunoki T . The Japan home-health apparatus industrial association: investigation of home-use electronic sphygmomanometers. Blood Press Monit 2001; 6: 303\u2013307.","journal-title":"Blood Press Monit"},{"key":"BFhr201111_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R . Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002; 39: 257\u2013265.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201111_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/1358863X9700200203","volume":"2","author":"A Uehata","year":"1997","unstructured":"Uehata A, Lieberman EH, Gerhard MD, Anderson TJ, Ganz P, Polak JF, Creager MA, Yeung AC . Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery. Vasc Med 1997; 2: 87\u201392.","journal-title":"Vasc Med"},{"key":"BFhr201111_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0009-8981(92)90176-Q","volume":"212","author":"T Adachi","year":"1992","unstructured":"Adachi T, Ohta H, Yamada H, Futenma A, Kato K, Hirano K . Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta 1992; 212: 89\u2013102.","journal-title":"Clin Chim Acta"},{"key":"BFhr201111_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412\u2013419.","journal-title":"Diabetologia"},{"key":"BFhr201111_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1042\/cs0840407","volume":"84","author":"NJ Miller","year":"1993","unstructured":"Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A . A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 1993; 84: 407\u2013412.","journal-title":"Clin Sci (Lond)"},{"key":"BFhr201111_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0003-2697(90)90002-Q","volume":"184","author":"JD Morrow","year":"1990","unstructured":"Morrow JD, Harris TM, Roberts II LJ . Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem 1990; 184: 1\u201310.","journal-title":"Anal Biochem"},{"key":"BFhr201111_CR22","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982\u2013992.","journal-title":"Am J Kidney Dis"},{"key":"BFhr201111_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.jhh.1001577","volume":"17","author":"SG Chrysant","year":"2003","unstructured":"Chrysant SG, Marbury TC, Robinson TD . Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension. J Hum Hypertens 2003; 17: 425\u2013432.","journal-title":"J Hum Hypertens"},{"key":"BFhr201111_CR24","first-page":"563","volume":"15","author":"Y Kimura","year":"1999","unstructured":"Kimura Y, Matsumoto M, Den YB, Iwai K, Munehira J, Hattori H, Hoshino T, Yamada K, Kawanishi K, Tsuchiya H . Impaired endothelial function in hypertensive elderly patients evaluated by high resolution ultrasonography. Can J Cardiol 1999; 15: 563\u2013568.","journal-title":"Can J Cardiol"},{"key":"BFhr201111_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/01.CIR.0000140265.21608.8E","volume":"110","author":"D Fliser","year":"2004","unstructured":"Fliser D, Buchholz K, Haller H . Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 2004; 110: 1103\u20131107.","journal-title":"Circulation"},{"key":"BFhr201111_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijcard.2008.11.017","volume":"140","author":"KK Koh","year":"2010","unstructured":"Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Koh Y, Shin EK . Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs. Int J Cardiol 2010; 140: 73\u201381.","journal-title":"Int J Cardiol"},{"key":"BFhr201111_CR27","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/01.hjh.0000220405.38622.23","volume":"24","author":"U Landmesser","year":"2006","unstructured":"Landmesser U, Drexler H . Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide. J Hypertens Suppl 2006; 24: S39\u2013S43.","journal-title":"J Hypertens Suppl"},{"key":"BFhr201111_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ejphar.2005.04.004","volume":"516","author":"V De Gennaro Colonna","year":"2005","unstructured":"De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G . Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 2005; 516: 253\u2013259.","journal-title":"Eur J Pharmacol"},{"key":"BFhr201111_CR29","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/01.ATV.20.10.2175","volume":"20","author":"KK Griendling","year":"2000","unstructured":"Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M . Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20: 2175\u20132183.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr201111_CR30","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1172\/JCI118623","volume":"97","author":"S Rajagopalan","year":"1996","unstructured":"Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG . Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916\u20131923.","journal-title":"J Clin Invest"},{"key":"BFhr201111_CR31","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/01.CIR.101.20.2349","volume":"101","author":"A Prasad","year":"2000","unstructured":"Prasad A, Tupas-Habib T, Schenke WH, Mincemoyer R, Panza JA, Waclawin MA, Ellahham S, Quyyumi AA . Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation 2000; 101: 2349\u20132354.","journal-title":"Circulation"},{"key":"BFhr201111_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/hr.2010.235","volume":"34","author":"LA Rabelo","year":"2011","unstructured":"Rabelo LA, Alenina N, Bader M . ACE2-angiotensin-(1-7)-mas axis and oxidative stress in cardiovascular disease. Hypertens Res 2011; 34: 154\u2013160.","journal-title":"Hypertens Res"},{"key":"BFhr201111_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1291\/hypres.31.553","volume":"31","author":"M Igase","year":"2008","unstructured":"Igase M, Kohara K, Nagai T, Miki T, Ferrario CM . Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade. Hypertens Res 2008; 31: 553\u2013559.","journal-title":"Hypertens Res"},{"key":"BFhr201111_CR34","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/01.ATV.15.11.2032","volume":"15","author":"P Stralin","year":"1995","unstructured":"Stralin P, Karlsson K, Johansson BO, Marklund SL . The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995; 15: 2032\u20132036.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr201111_CR35","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1161\/01.CIR.101.19.2264","volume":"101","author":"U Landmesser","year":"2000","unstructured":"Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B . Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2000; 101: 2264\u20132270.","journal-title":"Circulation"},{"key":"BFhr201111_CR36","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jacc.2007.06.013","volume":"50","author":"M Naya","year":"2007","unstructured":"Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H . Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. J Am Coll Cardiol 2007; 50: 1144\u20131149.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201111_CR37","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296\u20131305.","journal-title":"N Engl J Med"},{"key":"BFhr201111_CR38","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.amjmed.2006.01.013","volume":"119","author":"A Barnett","year":"2006","unstructured":"Barnett A . Prevention of loss of renal function over time in patients with diabetic nephropathy. Am J Med 2006; 119: S40\u2013S47.","journal-title":"Am J Med"},{"key":"BFhr201111_CR39","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S . Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861\u2013869.","journal-title":"N Engl J Med"},{"key":"BFhr201111_CR40","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1111\/j.1523-1755.2004.09211.x","volume":"92","author":"CD Stehouwer","year":"2004","unstructured":"Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM . Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction\u2014the Hoorn Study. Kidney Int Suppl 2004; 92: S42\u2013S44.","journal-title":"Kidney Int Suppl"},{"issue":"Suppl 2","key":"BFhr201111_CR41","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1097\/00005344-200606001-00009","volume":"47","author":"P Ochodnicky","year":"2006","unstructured":"Ochodnicky P, Henning RH, van Dokkum RP, de Zeeuw D . Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage. J Cardiovasc Pharmacol 2006; 47 (Suppl 2): S151\u2013S162; discussion S172\u2013S176.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr201111_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.diabres.2008.10.013","volume":"83","author":"H Ikeda","year":"2009","unstructured":"Ikeda H, Hamamoto Y, Honjo S, Nabe K, Wada Y, Koshiyama H . Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes. Diabetes Res Clin Pract 2009; 83: 117\u2013118.","journal-title":"Diabetes Res Clin Pract"},{"key":"BFhr201111_CR43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","volume":"103","author":"C Zhang","year":"2008","unstructured":"Zhang C . The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol 2008; 103: 398\u2013406.","journal-title":"Basic Res Cardiol"},{"key":"BFhr201111_CR44","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1161\/01.ATV.0000159890.10526.1e","volume":"25","author":"E Qamirani","year":"2005","unstructured":"Qamirani E, Ren Y, Kuo L, Hein TW . C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 2005; 25: 995\u20131001.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr201111_CR45","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/hr.2009.66","volume":"32","author":"M Sugihara","year":"2009","unstructured":"Sugihara M, Miura S, Takamiya Y, Kiya Y, Arimura T, Iwata A, Kawamura A, Nishikawa H, Uehara Y, Saku K . Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation. Hypertens Res 2009; 32: 625\u2013630.","journal-title":"Hypertens Res"},{"key":"BFhr201111_CR46","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/hr.2010.85","volume":"33","author":"G Derosa","year":"2010","unstructured":"Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, Fogari E, D\u2019Angelo A, Cicero AF . Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients. Hypertens Res 2010; 33: 790\u2013795.","journal-title":"Hypertens Res"},{"key":"BFhr201111_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1291\/hypres.31.7","volume":"31","author":"S Nakayama","year":"2008","unstructured":"Nakayama S, Watada H, Mita T, Ikeda F, Shimizu T, Uchino H, Fujitani Y, Hirose T, Kawamori R . Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension. Hypertens Res 2008; 31: 7\u201313.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:07:47Z","timestamp":1684429667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,10]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["BFhr201111"],"URL":"https:\/\/doi.org\/10.1038\/hr.2011.11","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,10]]}}}